STOCK TITAN

Cheelcare to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference

(Neutral)
(Very Positive)
Tags

Cheelcare (OTC: CHCRF) will present at the 2026 Bloom Burton & Co. Healthcare Investor Conference in Toronto on April 21-22, 2026. The company presentation is scheduled for Wednesday, April 22, 2026 at 3:30 PM ET.

CEO Eugene Cherny and VP of Growth Allan Boyd will deliver the presentation and hold one-on-one investor meetings during the conference.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Markham, Ontario--(Newsfile Corp. - April 14, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, announced today that it will participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference take place April 21-22, 2026, at the Metro Toronto Convention Centre in Toronto, Canada.

Cheelcare's CEO, Eugene Cherny and VP of Growth, Allan Boyd will present and participate in one-on-one meetings with investors and industry stakeholders throughout the conference.

Details on presentation are as follows:

Date: Wednesday, April 22, 2026
Time: 3:30 PM ET

The Bloom Burton & Co. Healthcare Investor Conference brings together American, Canadian, and international investors interested in the latest developments in the Canadian healthcare sector. Attendees will have the opportunity to receive corporate updates from leading Canadian publicly traded and private companies through formal presentations and private meetings.

About Bloom Burton & Co.

Bloom Burton & Co. is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies. Bloom Burton has an experienced team of medical, scientific, industry, and capital markets professionals who perform deep diligence. Combined with a creative and entrepreneurial approach, this expertise assists clients in achieving meaningful monetization events.

Bloom Burton and its affiliates provide services including capital raising, mergers and acquisitions advisory, equity research, strategic advisory, as well as company creation and incubation services. Bloom Burton Securities Inc. is a member of the Canadian Investment Regulatory Organization (CIRO) and the Canadian Investor Protection Fund (CIPF).

About Cheelcare Inc.

Cheelcare designs and manufactures innovative mobility solutions that empower independence for people with disabilities. From the Companion power assist devices to the groundbreaking Curio robotic complex-rehab power wheelchair, Cheelcare combines engineering excellence with human-centered design to improve quality of life. For more information, please visit: www.cheelcare.ca.

For further information, please contact:

Sofiya Kagan, Director of Marketing
Cheelcare Inc.
Tel: 1-888-948-2680 x 206
Email: skagan@cheelcare.com

Forward-Looking Information:

This news release may contain forward-looking statements. Forward-looking statements are based on current expectations and involve known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those expressed or implied. Such factors include, but are not limited to, general economic conditions, market demand, supply chain disruptions, and regulatory approvals. Any forward-looking statements are made as of the date of this news release, and the Company does not undertake to update any forward-looking statements except in accordance with applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/292173

FAQ

When and where will Cheelcare (CHCRF) present at the Bloom Burton & Co. conference in 2026?

Cheelcare will present on Wednesday, April 22, 2026 at 3:30 PM ET in Toronto. According to the company, the presentation takes place at the Metro Toronto Convention Centre during the Bloom Burton & Co. Healthcare Investor Conference April 21-22, 2026.

Who from Cheelcare (CHCRF) will speak and meet investors at the April 2026 conference?

Cheelcare's CEO Eugene Cherny and VP of Growth Allan Boyd will present and meet investors. According to the company, both executives will deliver the presentation and participate in one-on-one meetings with investors and industry stakeholders throughout the event.

What topics will Cheelcare (CHCRF) cover in its April 22, 2026 presentation?

The presentation will provide corporate updates and recent developments in advanced mobility solutions. According to the company, attendees can expect an overview of Cheelcare's business progress and opportunities, plus private meetings for more detailed investor discussions.

How can investors attend Cheelcare's (CHCRF) presentation at the Bloom Burton & Co. 2026 conference?

Investors can attend in person at the Metro Toronto Convention Centre during April 21-22, 2026. According to the company, the presentation is scheduled for April 22 at 3:30 PM ET and one-on-one meetings will be arranged during the conference.